Dabrafenib Impurity 23 CAS CATO-C4X-303323
| CAS No. | CATO-C4X-303323 |
| Molecular Formula | C17H13FIN3O4 |
| Molecular Weight | 469.21 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Dabrafenib Impurity 23 (CAS CATO-C4X-303323), a pharmacopoeial impurity reference standard (molecular formula C17H13FIN3O4, MW 469.21 g/mol) used for the identification and quantification of trace impurities in APIs.
Based on its molecular formula C17H13FIN3O4, Dabrafenib Impurity 23 contains a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine/iodine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 469.21 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
As a certified reference material (CRM), Dabrafenib Impurity 23 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C17H13FIN3O4 |
| Molecular Weight | 469.21 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F/I-containing |
| Nitrogen Atoms | 3 |
Related Dabrafenib Standards
- Dabrafenib Impurity 10 (CAS CATO-C4X-303310)
- Dabrafenib Impurity N6 (CAS 1195768-20-7)
- Dabrafenib Impurity 4 (CAS CATO-C4X-30334)
- Dabrafenib Impurity 22 (CAS CATO-C4X-303322)
- Dabrafenib Impurity 32 (CAS CATO-C4X-303332)
- Dabrafenib Impurity 17 (CAS 1613724-51-8)
- Dabrafenib Impurity N1 (CAS 1195765-47-9)
- Dabrafenib Impurity 2 (CAS CATO-C4X-30332)
Recommended Standards
- N-butyl-2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctanamide (CAS 37696-83-6)
- 6,7-Dichloro-4-(4-fluorophenyl)-2-(4-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one (CAS 161716-26-3)
- 7-Bromo-2-oxo-8-(piperidin-1-ylmethyl)-2H-selenopheno[3,2-h]chromene-3-carboxylic acid (CAS 2173398-19-9)
- 2,2'-((2,2-Bis(chloromethyl)propane-1,3-diyl)bis(oxy))bis(5,5-dimethyl-1,3,2-dioxaphosphinane 2-oxide) (CAS 83044-97-7)
- Aripiprazole Impurity 3 (CAS 129722-34-5)
- Ganirelix lmpurity 10 (CAS CATO-C4X-237310)
- Avibactam Impurity 85 (CAS 2733516-71-5)
- n-Isopropylpiperidine-3-sulfonamide (CAS 1016785-06-0)
- 2-Isopropyl-2H-1,2,3-triazol-4-amine hydrochloride (CAS 1365969-48-7)
- 2-{[3-(trifluoromethyl)phenyl]methanesulfonyl}quinoxaline (CAS 338977-88-1)
- 5-Amino-n-(cyclopropylmethyl)-2-methoxybenzenesulfonamide (CAS 1039971-06-6)
- 4-(3-Bromo-2,2-dimethylpropyl)-1,2-dimethylbenzene (CAS 1485909-22-5)
- 1-{2-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl}-2-phenylethan-1-one (CAS 1795393-63-3)
- Semaglutide impurity 198 (CAS CATO-C4X-2226198)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com